EDGAR Filing Documents for 0001493152-22-015610

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001493152-22-015610

Filing Date

2022-06-01

Accepted

2022-06-01 16:30:56

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		forms-3.htm	S-3	726752
2		ex1-2.htm	EX-1.2	246537
3		ex4-1.htm	EX-4.1	770186
4		ex4-2.htm	EX-4.2	809000
5		ex5-1.htm	EX-5.1	35122
6		ex23-1.htm	EX-23.1	5510
7	CALCULATION OF FILING FEE TABLES	ex107.htm	EX-FILING FEES	91147
8		forms-3_001.jpg	GRAPHIC	5932
9		ex5-1_001.jpg	GRAPHIC	3359
	Complete submission text file	0001493152-22-015610.txt		2698366

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019

Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760

Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)